Septerna (SEPN) Other Non Operating Income (2023 - 2026)
Septerna (SEPN) recorded quarterly Other Non Operating Income of -$31000.0 in Q1 2026, up 24.39% quarter-over-quarter from -$41000.0 in Q4 2025, and down 10.71% on a YoY basis from -$34720.0 in Q1 2025.
Septerna (SEPN) Other Non Operating Income (2023 - 2026) Analysis & Trends
Septerna's Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$31000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 10.71% year-over-year to -$31000.0; the TTM figure through Mar 2026 stood at -$103000.0 (down 47.14% YoY), while the FY2025 annual figure was -$100000.0, down 11.11% from the prior year.
- Other Non Operating Income was -$31000.0 for Q1 2026 at Septerna, up from -$41000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $13000.0 in Q4 2023 to a low of -$48000.0 in Q1 2024.
- Historically, Other Non Operating Income has averaged -$19000.0 across 4 years, with a median of -$18000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income plunged 800.0% in 2024, then jumped 41.67% in 2025.
- A 4-year view of Other Non Operating Income shows it stood at $13000.0 in 2023, then tumbled by 238.46% to -$18000.0 in 2024, then plunged by 127.78% to -$41000.0 in 2025, then increased by 24.39% to -$31000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$31000.0 (Q1 2026), -$41000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31,000.00 |
| Dec 31, 2025 | -41,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Dec 31, 2024 | -18,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | -1,000.00 |